ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Accelerator Applications
The division was organized to promote the advancement of knowledge of the use of particle accelerator technologies for nuclear and other applications. It focuses on production of neutrons and other particles, utilization of these particles for scientific or industrial purposes, such as the production or destruction of radionuclides significant to energy, medicine, defense or other endeavors, as well as imaging and diagnostics.
Meeting Spotlight
2024 ANS Annual Conference
June 16–19, 2024
Las Vegas, NV|Mandalay Bay Resort and Casino
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
May 2024
Jan 2024
Latest Journal Issues
Nuclear Science and Engineering
June 2024
Nuclear Technology
Fusion Science and Technology
Latest News
Strontium: Supply-and-demand success for the DOE’s Isotope Program
The Department of Energy’s Isotope Program (DOE IP) announced last week that it would end its “active standby” capability for strontium-82 production about two decades after beginning production of the isotope for cardiac diagnostic imaging. The DOE IP is celebrating commercialization of the Sr-82 supply chain as “a success story for both industry and the DOE IP.” Now that the Sr-82 market is commercially viable, the DOE IP and its National Isotope Development Center can “reassign those dedicated radioisotope production capacities to other mission needs”—including Sr-89.
L. Lebaron-Jacobs, R. Fottorino, F. Barbry, P. Berard, F. Briot, P. Boisson, D. Cavadore, C. Challeton-de Vathaire, S. Distinguin, L. Exmelin, A. Flury-Herard, E. Gaillard-Lecanu, M. Gonin, J.-P. Le Goff, G. Lecoix, G. Lemaire, R. Medioni, M. H. Persico, Y. Racine, C. Riasse, E. Rongier, P. Voisin, A. Miele
Nuclear Technology | Volume 161 | Number 1 | January 2008 | Pages 27-34
Technical Paper | Reactor Safety | doi.org/10.13182/NT08-A3910
Articles are hosted by Taylor and Francis Online.
A working group from health occupational and clinical biochemistry services on French sites has issued essential data sheets on the guidelines to follow in managing the victims of a criticality accident. Since the priority of the medical management after a criticality accident is to assess the dose and the distribution of dose, some dosimetric investigations have been selected in order to provide a prompt response and to anticipate the final dose reconstruction. Comparison exercises between clinical biochemistry laboratories on French sites were carried out to confirm that each laboratory maintained the required operational methods for hair treatment and the appropriate equipment for 32P activity in hair and 24Na activity in blood measurements, and to demonstrate its ability to rapidly provide neutron dose estimates after a criticality accident. As a result, a relation has been assessed to estimate the dose and the distribution of dose according to the neutron spectrum following a criticality accident.